Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AKT inhibitors in research and application

Dr Brian Schwartz - ArQule, Burlington, USA
AKT inhibitors in research and application ( Dr Brian Schwartz - ArQule, Burlington, USA )
25 Apr 2018

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Dr Irati Garmendia - University of Navarra, Pamplona, Spain
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression ( Dr Irati Garmendia - University of Navarra, Pamplona, Spain )
25 Apr 2018

Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes

Jon Obenauer - Rancho BioSciences, Rancho Santa Fe, USA
Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes ( Jon Obenauer - Rancho BioSciences, Rancho Santa Fe, USA )
25 Apr 2018

Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.

Prof Alex Eggermont - Paris-Sud University, Paris, France
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab. ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 :  Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018

Immunotherapy and targeted treatments in breast cancer reviewed

Dr Hesham El Ghazaly and Prof Leisha Emens
Immunotherapy and targeted treatments in breast cancer reviewed ( Dr Hesham El Ghazaly and Prof Leisha Emens )
29 Jan 2018

The best sequence of anti-HER2 therapy in metastatic breast cancer

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain
The best sequence of anti-HER2 therapy in metastatic breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )
29 Jan 2018

ESO-ESMO-ABC guidelines in metastatic breast cancer

Dr Nagi El Saghir - American University of Beirut, Beirut, Lebanon
ESO-ESMO-ABC guidelines in metastatic breast cancer ( Dr Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
26 Jan 2018

BGICC conference highlights: Changing standards in breast and gynaecological cancers

Dr Hesham El Ghazaly - Ain Shams University, Cairo, Egypt
BGICC conference highlights: Changing standards in breast and gynaecological cancers ( Dr Hesham El Ghazaly - Ain Shams University, Cairo, Egypt )
26 Jan 2018

Management of inflammatory breast cancer

Prof Marwan Ghosn - Saint-Joseph University, Beirut, Lebanon
Management of inflammatory breast cancer ( Prof Marwan Ghosn - Saint-Joseph University, Beirut, Lebanon )
26 Jan 2018